Shell $SHEL to buy ARC $ARX for $16.4B; adds 370,000 boe/d in Montney

Shell $SHEL has agreed to buy ARC Resources $ARX in a $16.4B transaction, putting one of Canada’s biggest Montney producers inside Shell’s integrated gas system. Shell shares were slightly lower in premarket trading, but the strategic math is bigger than the immediate tape: the deal adds roughly 370,000 barrels of oil equivalent per day and raises Shell’s production CAGR through 2030 to 4%, versus the 1% trajectory it outlined at its 2025 capital markets day.

In Shell’s deal announcement and CNBC’s market report, the company said ARC holders will receive C$8.20 in cash and 0.40247 Shell shares for each ARC share. That works out to C$32.80 a share, a 20% premium to ARC’s 30-day VWAP as of April 24. Shell put the equity value at about $13.6B and said it will assume about $2.8B of net debt and leases, taking enterprise value to $16.4B. The group also guided to roughly $250M of annualized synergies within a year of closing.

The portfolio logic is straightforward. ARC brings more than 1.5 million net acres in the Montney, about 2 billion boe of proved-plus-probable reserves at year-end 2025, and a liquids mix that generated around 70% of revenue last year. Shell said ARC’s gas base can reinforce LNG Canada, where Shell owns 40%, and that the acquired business will sit inside its Integrated Gas division. CEO Wael Sawan called ARC a “high-quality, low-cost” producer that strengthens Shell’s Canadian resource base for decades.

What matters next is execution. Shell expects closing in H2 2026, subject to ARC shareholder, court and regulatory approvals, while keeping its 2027-2028 cash capex range unchanged at $20B-$22B. Investors will watch dilution from roughly 228 million new Shell shares, the promise of free-cash-flow accretion from 2027, and whether a larger Montney footprint gives Shell more LNG-linked cash flow without forcing a rethink of capital returns or balance-sheet discipline.

Not investment advice. Verify all figures with primary sources before acting.